Insmed (INSM) Invested Capital (2011 - 2026)

Insmed has reported Invested Capital for 16 years, with the latest figure at $1.3 billion in Q2 2026.

• On a quarterly basis, Invested Capital fell 27.4% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 27.4% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 7.84% from the prior year.
• Invested Capital was $1.3 billion for Q2 2026 at Insmed, up from $1.3 billion in the prior quarter.
• The five-year high for Invested Capital was $1.8 billion in Q2 2025, with the low at $770.0 million in Q3 2022.
• Average Invested Capital over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Invested Capital slumped 40.99% in 2022, then surged 68.66% in 2024.
• Over 5 years, Invested Capital stood at $1.2 billion in 2022, then plunged by 32.13% to $823.4 million in 2023, then soared by 68.66% to $1.4 billion in 2024, then slipped by 7.84% to $1.3 billion in 2025, then rose by 1.9% to $1.3 billion in 2026.
• The last three Invested Capital figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.